Charles Schwab Investment Management Inc. decreased its holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 19.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 314,877 shares of the business services provider's stock after selling 74,288 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.96% of Cross Country Healthcare worth $5,718,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of CCRN. Truvestments Capital LLC purchased a new position in Cross Country Healthcare during the third quarter worth about $39,000. Plato Investment Management Ltd acquired a new stake in shares of Cross Country Healthcare during the fourth quarter worth about $46,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in Cross Country Healthcare during the third quarter worth approximately $49,000. Point72 DIFC Ltd purchased a new stake in Cross Country Healthcare in the third quarter valued at approximately $52,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Cross Country Healthcare by 14.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,169 shares of the business services provider's stock valued at $137,000 after acquiring an additional 1,250 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.
Cross Country Healthcare Price Performance
NASDAQ CCRN traded down $0.11 on Friday, hitting $15.00. 272,561 shares of the company's stock were exchanged, compared to its average volume of 597,150. The firm's 50-day moving average price is $17.11 and its two-hundred day moving average price is $15.19. The firm has a market cap of $492.20 million, a price-to-earnings ratio of -299.94, a P/E/G ratio of 3.32 and a beta of 0.44. Cross Country Healthcare, Inc. has a fifty-two week low of $9.58 and a fifty-two week high of $19.14.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. William Blair cut shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 4th. Truist Financial increased their target price on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the stock a "hold" rating in a research note on Thursday, December 5th. Barrington Research restated a "market perform" rating and issued a $18.61 price target on shares of Cross Country Healthcare in a research report on Friday, March 14th. Benchmark cut Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, December 4th. Finally, JMP Securities reiterated a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Six investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $18.41.
Check Out Our Latest Report on Cross Country Healthcare
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Articles

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.